Trials / Completed
CompletedNCT02512003
Pilot Study of the Fantom Bioresorbable Scaffold (FANTOM I)
Pilot Study of the REVA Sirolimus-Eluting Bioresorbable Coronary Scaffold
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- REVA Medical, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The FANTOM I pilot study is intended to assess safety of the Fantom Bioresorbable Coronary Scaffold in native coronary arteries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Fantom Scaffold |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-07-01
- Completion
- 2020-04-01
- First posted
- 2015-07-30
- Last updated
- 2023-03-29
Locations
2 sites across 2 countries: Brazil, Poland
Source: ClinicalTrials.gov record NCT02512003. Inclusion in this directory is not an endorsement.